Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130 a Abs. 8 SGB V mit dem Wirkstoff Fusidinsäure in der Darreichungsform ATR

TENDER DESCRIPTION

GWQ ServicePlus AG intends to conclude non-exclusive rebate agreements pursuant to § 130a para. 8 SGB V for the aforementioned active substance with a contract start on 01.09.2026. All interested companies may join this contract at any time during the contract period under the same conditions (admission model). GWQ assumes that this procedure does not fall within the scope of cartel procurement law due to the absence of a selection decision and thus the non-discriminatory access possibility for all pharmaceutical companies. The contract documents, the participating health insurance funds and their turnover as well as the deadlines for the contract notification can be viewed and downloaded on the procurement portal of GWQ ServicePlus AG at https://vergabeportal.gwq-serviceplus.de/arzneimittel. Until the start of exclusive contracts, this transitional agreement is open to all market participants for accession. If the signed contracts / declarations and proofs are received by 10.08.2026, an initial notification can be realized as of 01.09.2026. The following documents must be submitted: signed contract in duplicate; proof of pharmaceutical marketing authorization by means of an…

TENDER BRIEF

TENDER DOCUMENTS